Unibest
← Back to patent-cliff list

Atosiban acetate

Tier C — Watch / trade

Atosiban acetate

-
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets：OT-R

Brand：Antocin, Tractocile

Indications (approved)：产科分娩（早产）, 早产（孕37周前）

Regional status

US
-
EU
Approved
2000-01-20
China
Approved
2006-04-06
Japan
-

Factories producing this API4

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

4 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Atosiban acetate?

Approved indications include: 产科分娩（早产）, 早产（孕37周前）.

When does the Atosiban acetate patent expire?

No public expiry year is available for Atosiban acetate yet; this page updates once verified.

How do I get a quote for Atosiban acetate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27